Lifecore Biomedical, Inc. (LFCR)
$6.42-0.31%Close
BUYRECOVERY · day 20
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $241M
- Beta
- 0.98
- P/E (TTM)
- -5.84
- Short % float
- 7.31%
- Days to cover
- 4.1
- SI change
- -7.3%
- 1W
- -0.47%
- 1M
- +51.06%
- vs SPY 1W
- -0.33%
- vs SPY 1M
- +48.55%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 0
- GROWTH
- 30
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-226.2%
REV YoY-
ROE-376.9%
EPS YoY-
ROA-16.2%
GROSS30
OP-2
NET-30
[VALUATION]
P/E TTM-5.84
P/E FWD-
SECTOR PE20.34
INDUSTRY PE19.31
P/B14.99
P/FCF-
EV/EBITDA-91.48
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E963.57
ALTMAN Z-
CURR RATIO3.87
ND/EBITDA-
BETA0.98
NET INCOME (TTM) < 0
Company news
FAQ
- What is LOPJLB’s current signal on LFCR?
- LOPJLB’s latest quantitative signal on Lifecore Biomedical, Inc. (LFCR) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is LFCR in?
- Lifecore Biomedical, Inc. (LFCR) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Lifecore Biomedical, Inc. (LFCR) do?
- Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical devic…